The tumoral beds of patients with inflammatory BC (IBC) and achieving pCR tend to be more infiltrated by CD163+ TAMs; however, in non-responders, TAMs can be found closer to cancer cells and CD8+ T cells [146]. Here, CD163 is linked to breast cancer.